Skip to main navigation Skip to search Skip to main content

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

  • EMBRACE Collaborators
  • , GC-HBOC Study Collaborators
  • , GEMO Study Collaborators
  • , ABCTB Investigators
  • , HEBON Investigators
  • , BCFR Investigators
  • QIMR Berghofer Medical Research Institute
  • Vanderbilt University
  • University of Cambridge
  • Helsinki University Central Hospital (HUCH)
  • Mount Sinai Hospital of University of Toronto
  • University of Toronto
  • University of California, Irvine
  • Landspitali University Hospital
  • University of Iceland
  • DKFZ (Deutsches Krebsforschungszentrum Heidelberg)
  • Queens University at Kingston
  • University of Texas MD Anderson Cancer Center
  • Comprehensive Cancer Center
  • Fondazione IRCCS
  • Vall D'Hebron Institute of Oncology
  • Friedrich-Alexander Universitat Erlangen Nurnberg
  • Centro de Investigación en Red de Enfermedades Raras (CIBERER)
  • Spanish National Cancer Research Centre
  • Ufa Scientific Center RAS
  • Pomeranian Medical University
  • Orebro University
  • Medizinische Hochschule Hannover (Hannover Medical School)
  • N.N. Alexandrov Research Institute of Oncology and Medical Radiology
  • Copenhagen University Hospital
  • University of Copenhagen
  • Lund University
  • Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
  • University of Tübingen
  • Netherlands Cancer Institute
  • University Womens Clinic Heidelberg
  • IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos)
  • University of Sydney
  • Royal Devon & Exeter NHS Foundation Trust
  • Sheffield Children's Hospital
  • University of Glasgow
  • University of Aberdeen
  • Newcastle-upon-Tyne Hospitals NHS Foundation Trust
  • The University of London
  • University of Dublin Trinity College
  • Birmingham Women's and Children's NHS Foundation Trust
  • University Hospital of Wales
  • Fox Chase Cancer Centre
  • Karolinska Institutet
  • University of Queensland
  • University of Melbourne
  • Parkville Familial Cancer Centre
  • The Institute of Cancer Research (University of London)
  • Ohio State University
  • Vanderbilt-Ingram Cancer Center

Research output: Contribution to journalArticlepeer-review

Abstract

Genome-wide association studies (GWAS) have identified more than 170 breast cancer susceptibility loci. Here we hypothesize that some risk-associated variants might act in non-breast tissues, specifically adipose tissue and immune cells from blood and spleen. Using expression quantitative trait loci (eQTL) reported in these tissues, we identify 26 previously unreported, likely target genes of overall breast cancer risk variants, and 17 for estrogen receptor (ER)-negative breast cancer, several with a known immune function. We determine the directional effect of gene expression on disease risk measured based on single and multiple eQTL. In addition, using a gene-based test of association that considers eQTL from multiple tissues, we identify seven (and four) regions with variants associated with overall (and ER-negative) breast cancer risk, which were not reported in previous GWAS. Further investigation of the function of the implicated genes in breast and immune cells may provide insights into the etiology of breast cancer.

Original languageEnglish
Article number1741
JournalNature Communications
Volume10
Issue number1
Early online date15 Apr 2019
DOIs
Publication statusPublished - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer'. Together they form a unique fingerprint.

Cite this